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1. Introduction
   Malaria remains the world most devastating human 
parasitic infection, afflicting more than 500 million people 
each year[1]. Mortality currently estimated at over a million 
people per year, has risen in recent years, probably due to 
increasing resistance to antimlarial medicines[2]. 
   The constant evolution of the malaria parasite has 
rendered the cheapest and most widely available 
antimalarial treatments ineffective, especially with 
the recent reports about the increasing resistance of 
Plasmodium falciparum (P. falciparum) to artemisinin-
based compounds[3-5]. 
  However, there is deep concern that this parasite will soon 
develop total resistance to such orthodox treatments. This 
has led researchers to look for other alternatives, one of 
which is evaluation of medicinal plants. Therefore, there is 
an urgent need to explore and utilize the naturally endowed 
rich biodiversity of communities through research that 
could translate to benefits for mankind. Hence, such studies 
on medicinal and beneficial plants could provide useful 
leads for the synthesis of important active compounds.
  Pseudocedrela kotschyi (P. kotschyi) is one of such 
medicinal plants whose therapeutic value no doubt has a 
folkloric background. The plant is found abundantly in the 
moisture of heavy soils. It has been used in the treatment 
of various diseases by traditional healers. Various extracts 
of the plant have been reported to possess antidiabetic, 
antiepileptic, analgesic, antipyretic and antimicrobial 
properties[6-9].
  The aim of the current study therefore is to investigate the 
ethanol leaf extract of P. kotschyi for antimalarial potency.
2.  Material and methods
2.1. Collection of plant material
  Fresh leaves of P. kotschyi were collected in the month of 
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April, 2010 from chaza village, Suleja, Niger State, Nigeria 
and duly authenticated in the Department of Medicinal 
Plant Research and Traditional Medicine, National Institute 
for Pharmaceutical Research and Development (NIPRD), 
Abuja, Nigeria by Dr. (Mrs) Jemilat A. Ibrahim. A specimen 
of the plant with voucher number (NIPRD/H/6542) was 
subsequently deposited at the herbarium of NIPRD for 
reference. The international plant name index is Meliaceae 
Pseudocedrela kotschyi. Bot. Jahrb. Syst. 22 (1): 154, 1895 (19 
Nov. 1895) (IK).
2.2. Extraction of plant material
  The leaves were cleaned and taken to the laboratory where 
they were cut into pieces and air-dried at room temperature 
for 7 d and ground to powder using mortar and pestle. Three 
hundred and fifty grams of the grounded leaf powder was 
then macerated in 1.5 L of ethanol for 24 h and filtered. The 
filtrate was dried on a water bath at reduced temperature to 
recover the extract and the yield calculated to be 38 g (11% 
w/w). The extract was stored in an airtight container and 
used for the study.
2.3. Phytochemical analysis
  The phytochemical screening of ethanol extract of
P. kotschyi leaf was carried out to determine the presence 
of the following compounds; alkaloids, tannins, saponins, 
terpenoides, flavonoids, steroids and cardiac glycosides, 
carbohydrates, reducing sugar, phlobatannins and 
anthraquinones  using standard procedures[10-12].
2.4. Experimental animals 
  Swiss albino mice (18-22 g) of both sexes were used for the 
study. The mice were bred and kept in the Animal House, 
Department of Pharmacology, College of Medical Sciences, 
University of Calabar, Nigeria. 
  The animals were housed in cages at room temperature 
and moisture, under naturally illuminated environment of 
12:12 h dark/light cycle. They were fed on standard diet and 
had free access to water. Treatment of the animals was in 
accordance with the Principles of Laboratory Animal Care 
(Revised)[13].
2.5. Acute toxicity of the extract
  The lethal dose (LD50) of the ethanol leaf extract of
P. kotschyi was determine in mice using the method as 
described by Lorke[14] with slight modification. Mice of both 
sexes were fasted overnight for the toxicity test. The study 
was done in two phases. In the first phase, 3 groups of 3 
mice per cage were administered 10, 100 and 1 000 mg/kg
of the extract p.o. The mice were observed for signs of 
toxicity and mortality for the first 4 h and 24 h. In the 
second phase, another 3 groups of 3 mice in each cage were 
further administered 1 600, 2 900 and 5 000 mg/kg of the leaf 
extract. The mice were also observed for signs of toxicity 
and mortality at regular intervals for 24 h, 48 h and 72 h 
respectively.   
2.6. Malaria parasites
  The chloroquine-sensitive Plasmodium berghei berghei 
(P. berghei berghei) (NK65) used to assess the antimalarial 
activity of P. kotschyi leaf was obtained from National 
Institute for Medical Research (NIMR) Lagos, and kept at the 
Department of Pharmacology, College of Medical Sciences, 
University of Calaba, Nigeria. The parasites were maintained 
by continuous re-infestation in mice.
2.7. Inocula 
  Parasitized erythrocytes were obtained from a donor 
infected mouse by cardiac puncture. This was prepared by 
determining percentage parasitaemia and the erythrocytes 
count of the donor mouse and diluting them with normal 
saline in proportions indicated by both determinations[15]. 
Each mouse was inoculated intraperitoneally with infected 
blood suspension (0.2 mL) containing 1×107 P. berghei 
berghei parasitized red blood cells.
2.8. Suppressive test
  A 4--day suppressive test as described by Akuodor et 
al[16], Mbah et al[17] Was employed for the study. Thirty Swiss 
albino mice of both sexes weighing (18-22 g) were passaged 
intraperitonealy with standard inocula of P. berghei 
containing 1×107 infected erythrocytes. Four hours after 
inoculation, the infected mice were randomly divided into 
5 groups of 6 mice per cage and treated for four consecutive 
days (D0-D3). Group 1 received 0.2 mL of normal saline 
(Drug-free control). Group 2, 3 and 4 received 100, 200 and 
400 mg/kg of the ethanol leaf extract respectively, while 
group 5 received 10 mg/kg of Chloroquine diphosphate. All 
doses were administered orally. On the fifth day (D4), thin 
films were made from the tail blood of each mouse. 
  The films were fixed with methanol, stained with 10% 
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Giemsa and parasite density determined by microscopically 
(Olympus CX 21, Japan) counting the parasitized red blood 
cells on at least 1 000 red blood cells in 10 different fields[15].
2.9. Repository test
  This was assessed by using the method described by[18,19]. 
Thirty Swiss albino mice of both sexes weighing (18-22 g) 
were randomly divided into 5 groups of 6 mice per cage 
for ethanol leaf extract of P. kotschyi. The mice were orally 
administered with various doses of the extract (50, 100 and 
200 mg/kg), 10 mg/kg chloroquine (reference group) and
0.2 mL normal saline (control group) for three consecutive 
days. 
  On the fourth day, the mice were passaged intraperitoneally 
with standard inocula of P. berghei berghei containing 1x107 
infected erythrocytes. Seventy-two hours later (D7), thin 
films were made from the tail blood of each mouse. The films 
were fixed with methanol, stained with 10% Giemsa and 
parasitaemia level assessed by microscopically (Olympus CX 
21, Japan) counting the parasitized red blood cells on at least 
1 000 red blood cells in 10 different fields[15].
2.10. Curative test
  On the first day (D0), thirty Swiss albino mice were 
passaged intraperitonealy with standard inocula of 1×107
P. berghei berghei infected erythrocytes. Seventy-
two hours after, the mice were randomly divided 
into 5 groups of 6 mice per cage.  Group 1 received 
0 . 2  m L  o f  n o r m a l  s a l i n e  ( D r u g - f r e e  c o n t r o l ) . 
Group 2, 3 and 4 received 100, 200 and 400 mg/kg
of the ethanol leaf extract respectively, while group 5 
received 10 mg/kg of Chloroquine diphosphate. All doses 
were administered orally. Treatment continued daily until 
the seventh day when thin films were made from the tail 
blood of each mouse. 
  The films were fixed with methanol, stained with Giemsa 
and parasitemia density examined by microscopically 
counting the parasitized red blood cells on at least 1 000 red 
blood cells in 10 different fields[20,21]. 
  The mean survival time of each group was determined by 
finding the average survival time (days) of the mice in each 
group over a period of 28 days (D0-D27).
2.11. Statistical analysis
  Results obtained were expressed as mean依S.E.M. The 
significance of difference between the controls and 
treated groups were determined using one-way analysis of 
variance (ANOVA. P<0.05 were considered to be statistically 
significant[22].
3. Results 
3.1. Phytochemical test
  Results obtained from the phytochemical screening of 
the ethanol leaf extract of P. kotschyi showed the presence 
of alkaloids, tannins, saponins, terpenoides, flavonoids, 
steroids, cardiac glycosides, carbohydrates, reducing sugar, 
while phlobatannins and anthraquinones were absent. 
3.2. Acute toxicity test
  There was no mortality recorded in the mice upon oral 
administration even at doses as high as 5 000 mg/kg. This 
indicates that the experimental doses used are relatively 
safe. 
3.3. Suppressive test
  The ethanol leaf extract of P. kotschyi demonstrated dose 
dependent schizonticidal activity at the doses employed in 
the study. The extract at 400 mg/kg caused 91% suppression 
as against 90% and 79% suppression induced by 200 and 100 
mg/kg respectively. The standard drug chloroquine however 
caused 94% suppression (Table 1). 
Table 1. 
Suppressive effect of ethanol leaf extract of P. kotchyi against P. berghei 
berghei in mice. 
Drug Dose (mg/kg) Mean Parasitemia 
density  (D5)
% Suppression
Normal saline 0.2 mL 30.3依0.5 -
P. kotchyi 100   6.4依0.6 79*
200   3.0依0.3                      90*
400   2.6依0.3 91*
Chloroquine   10   1.7依0.2 94*
D5= Day five, *significantly different from control at P<0.05 (n=6).
Table 2. 
Repository effect of ethanol leaf extract of P. kotchyi against P. berghei berghei 
in mice. 
Drug Dose (mg/kg) Mean Parasitemia 
density  (D7)
% Suppression
Normal saline 0.2 mL 28.9依0.6                      -
P. kotchyi 100   7.2依0.3                     75*
200   5.4依0.1                      81*
400   2.9依0.0 90*
Chloroquine   10   1.8依0.2                     94*
D7= Day seven, *significantly different from control at P<0.05 (n=6).
3.4. Repository test
  The ethanol leaf extract of P. kotschyi exhibited significant 
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(P<0.05) dose dependent reduction in parasitemia density of 
75%, 81% and 90% at 100, 200 and 400 mg/kg respectively, 
whereas chloroquine treated group caused 94% reduction in 
parasitemia density in the test (Table 2).
3.5. Curative test
  There was a dose dependent reduction in the level of 
parasitemia in the treated group unlike in the saline control 
group in which there a consistent increase in the blood 
parasite density. 
  The mean survival time also increased dose dependently. 
Death was observed in the control group on day 8 and by day 
11, all mice in the group died (mean survival time of 9 days). 
On the other hand, mice in the group that received 100, 200 
and 400 mg/kg survived beyond 21 days. Chloroquine treated 
group survived the 28 days duration of observation (Table 3).
4.  Discussion
  Phytochemicals  const i tute  an integral  par t  o f 
medicinal plants and are responsible for their numerous 
bioactivities. Numerous plants containing a wide variety 
of phytochemicals as their bioactive principle have 
antiplasmodial activities[23,24]. Although the mechanism 
of the action of the leaf extract has not been evaluated in 
the present study, some of the constituents detected have 
however been implicated in antiplasmodial activities by 
different mechanisms. The antiplasmodial activity of Berlina 
grandiflora has been tracked to the alkaloids, flavonoids and 
terpenoids contained in the plant[20].
  The ethanol leaf extract of P. kotschyi has been shown 
to possess schzonticidal activity in vivo following oral 
administration to infected mice. The extract demonstrated 
good schozonticidal activity against early infections at the 
various doses employed in the study.
  In the established infection, the ethanol leaf extract 
at various doses showed significant dose dependant 
schizonticidal activity. The observed antimalarial activity 
of the leaf extract is consistent with the traditional use of 
the plant as herbal medication against the disease and 
indicative of its potential as a chemotherapeutic antimalarial 
agent. The plant extract has a noteworthy antimalarial 
activity as the mean survival time values which at doses 
used were twice or more than that of control group. 
  In this study, chloroquine was used as the standard 
antimalarial drug. Chloroquine has been used for curative, 
suppressive and prophylactic antiplasmodial activities. 
In early and established infection, chloroquine interrupts 
with the heme polymerization by forming a FP-chloroquine 
complex. This complex is responsible for the disruption of 
the parasite’s cell membrane function and ultimately leads 
to auto digestion. Though, chloroquine exhibited higher 
suppressive, prophylactic and curative antiplasmodial 
activities by the extent of inhibition of parasitemia, the leaf 
extract of P. kotschyi also showed similar antiplasmodial 
activities. 
  P. berghei berghei has been used in studying the activity 
of potential antiplasmodials in vivo in rodents[25,26], and it 
produces diseases similar to those of human plasmodial 
infection[27,28]. Agents with suppressive activity against P. 
berghei berghei were known for antiplasmodial activity[29]. 
Earlier studies on extracts of P. kotschyi showed that it 
possess analgesic and antipyretic properties[7,8]. Agents with 
such properties are known to produce additional remedy to 
malaria patients[30].
  In conclusion, the extract has demonstrated significant 
antimalarial activity as seen in its ability to suppress P. 
berghei berghei infection in the three models evaluated. The 
findings lend pharmacological support to the folkloric use of 
the plant in the treatment of malaria.
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Table 3. 
Curative effect of ethanol leaf extract of P. kotchyi against P. berghei berghei in mice. 
                                                                                                               Mean parasitemia density
Drug Dose (mg/kg) Pre (D3) Post (D7) Mean survival time (Days)
Normal saline 0.2 mL 30.5依0.6 39.8依0.5   9.3依1.1
P. kotchyi 100 29.0依0.6   10.0依0.3* 22.7依1.9
200 28.5依0.6     8.7依0.5* 24.3依1.8
400 30.8依0.5     5.2依0.6* 27.2依1.3
Chloroquine 10 29.8依0.3     3.0依0.3* 28.0依0.0
D3=Day three, D7=Day seven, *significantly different from control at P<0.05 (n=6). All mice treated with chloroquine survived until day 28.
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